Neucore Bio is a preclinical-stage precision medicines company advancing nonviral gene therapy for the treatment of central and peripheral nervous system diseases and disorders of high unmet need. Our lead assets engineered EV delivered genetic therapies for neurofibromatosis.

Contact Neucore Bio
Visit Website